AccessibilityHelpAbout Us
Mycelx Technologies logo

Mycelx Technologies(LSE) MYX

Market Cap£13.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2012)-79%
5 Year+45%
1 Year+102%
1 Month+21%
£0.55
+8.29%
+0.04Today
Mycelx Technologies last closing stock price
MetricPriceDate
Last closeGBX 54.502026-09-11
Mycelx Technologies stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week+7.92%GBX 50.502026-09-04
1 month+21.11%GBX 45.002026-08-12
3 month-17.42%GBX 66.002026-06-12
Year to date+101.85%GBX 27.002025-12-31
1 year+101.85%GBX 27.002025-09-11
3 year+12.37%GBX 48.502023-09-12
5 year+45.33%GBX 37.502021-09-10
Since inception-78.63%GBX 2.552012-10-10

Mycelx Technologies Financials at a Glance

Market Cap

£13.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

$16.65M

Net Income (TTM)

-$2.39M

EPS (TTM)

-£0.10

P/E Ratio

-5.20

Dividend

£0.00

Beta (Volatility)

0.17 (Low)

Price

£0.55

Volume

14,338

Open

£0.54

Previous Close

£0.55

Daily Range

£0.54 - £0.55

52-Week Range

£0.20 - £0.68

Estimated Earnings Date

May 20, 2027

MYX News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Mycelx Technologies

MYCELX Technologies Corporation is a clean water technology firm specializing in water purification systems for various industries, including petroleum and power generation. Established in 1994, the company operates globally, providing innovative solutions to enhance water quality and sustainability.

Products and Services
  • Water purification systems for industrial applications
  • Proprietary equipment for oil extraction from produced water
  • Replaceable filtration media for ongoing operations
Growth Outlook
  • Recent quarterly revenue reached $10.07 million, a significant increase
  • Expansion into new international markets is underway
  • Focus on sustainable solutions aligns with global environmental trends
Financial Highlights
  • Trailing twelve months (TTM) revenue of $12.4 million reflects growth potential
  • Operating income margin improved to 22.4% in the latest quarter
  • Current ratio of 2.45 indicates strong liquidity position
MYCELX Technologies Corporation is positioned to capitalize on the growing demand for clean water solutions across various sectors. The company's innovative products and services address critical environmental challenges, making it a key player in the industrial pollution and treatment controls industry. Recent financial performance shows promising growth, with a notable increase in quarterly revenue and improved operating margins. The strong liquidity position further supports the company's ability to invest in future growth opportunities. As global focus on sustainability intensifies, MYCELX is well-placed to meet the evolving needs of its customers while contributing to environmental preservation.
AI Generated • Sep 11, 2026

Industry

Commercial Services and Supplies

Sector

Industrials

CEO

Connie Mixon, MBA

Website

mycelx.com

Headquarters

Norcross, GA 30093, US

MYX Financials

Key Financial Metrics (TTM)

Gross Margin

47.83%

Operating Margin

1.64%

Net Income Margin

2.84%

Return on Equity

7.39%

Return on Capital

2.79%

Return on Assets

3.85%

Earnings Yield

-19.23%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

£13.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

24.36M

Volume

14.34K

Avg. Volume

23.52K

Financials (TTM)

Gross Profit

$6.96M

Operating Income

-$4.36M

EBITDA

-$3.05M

Operating Cash Flow

-$3.01M

Capital Expenditure

-$66.50K

Free Cash Flow

-$3.08M

Cash & ST Invst.

$812.00K

Total Debt

$1.26M

Mycelx Technologies Performance Analysis

Mycelx Technologies annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20212021-12-31USD 6,164,456N/A
20222022-12-31USD 8,139,43932.0%
20232023-12-31USD 8,774,3737.8%
20242024-12-31USD 3,837,027-56.3%
Mycelx Technologies sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-30-34.4%
Q42024-12-31-59.9%
Q22025-06-3019.0%
Q42025-12-31503.1%
Mycelx Technologies annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20212021-12-31USD -0.05N/A
20222022-12-31USD -0.15173.5%
20232023-12-31USD -0.13-11.0%
20242024-12-31USD -0.09-29.8%
Mycelx Technologies sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q22024-06-3038.2%
Q42024-12-31-1.4%
Q22025-06-30-33.3%
Q42025-12-31212.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$10.07M

+88.6%

Gross Profit

$4.92M

+258.3%

Gross Margin

48.85%

N/A

Market Cap

£13.28MMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

£737.68K

N/A

Employees

18

N/A

Net Income

$2.25M

+202.2%

EBITDA

$3.02M

+289.8%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Total Cash

$812.00K

+112.0%

Total Debt

$1.26M

+41.8%

Accounts Receivable

$3.18M

+54.0%

Inventory

$2.25M

-34.2%

Long Term Debt

$412.00K

-32.1%

Short Term Debt

$849.00K

+201.1%

Return on Assets

3.85%

N/A

Return on Invested Capital

3.18%

N/A

Free Cash Flow

-$281.00K

+72.0%

Operating Cash Flow

-$256.00K

+74.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
THRU.LThruvision Group plc
£0.03+5.77%
LPA.LLPA Group Plc
£0.84+8.39%
CEPS.LCEPS Plc
£0.41+0.00%
TGP.LTekmar Group plc
£0.14-1.75%

Trending Stocks

Symbol / CompanyPricePrice Chg
KHCKraft Heinz
$24.60+0.01%
ACVAACV Auctions
$10.41+0.44%
TNONTenon Medical
$5.93+0.12%
ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF
$19.16+0.03%

Questions About MYX

What is the current price of Mycelx Technologies?

Mycelx Technologies is trading at £0.55 per share.

What is the 52-week range for Mycelx Technologies?

Over the past 52 weeks, Mycelx Technologies has traded between £0.20 and £0.68.

How much debt does Mycelx Technologies have?

As of the most recent reporting period, Mycelx Technologies reported total debt of $1.00M.

How much cash does Mycelx Technologies have on hand?

Mycelx Technologies reported $1.05M in cash and cash equivalents in its most recent financial results.

What is Mycelx Technologies’s dividend yield?

Mycelx Technologies does not currently have a dividend yield.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services